Treatments for prolonged cough in children
Official title: A Randomized, Double-blinded Clinical Trial Comparing the Efficacy of Antibiotic or Inhaled Corticosteroid to Placebo in Children´s Protracted Cough
Run by Tampere University Hospital · NCT07582549 · Data updated 2026-11-12
It tests whether an inhaled steroid helps children with dry prolonged cough and whether an antibiotic helps children with wet prolonged cough compared with placebo.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 1 Year to 6 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Tampere University Hospital Academic / other |
| Locations | 1 site (Tampere) |
| Status | Recruiting |
| Started | December 22, 2025 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | May 13, 2026 |
| Trial ID | NCT07582549 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children who have had a daily cough for more than four weeks, are otherwise generally healthy with no identified cause on routine examinations, and whose parents can give written informed consent in Finnish are eligible.
✕Probably not a fit
Children with a known underlying disease explaining the cough, chronic conditions requiring continuous medication, prior severe allergy to fluticasone or amoxicillin–clavulanate, or concurrent participation in another drug trial are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Children with a cough lasting more than four weeks receive standard clinical screening including lung function tests and a chest X-ray; if no clear cause is found they may enter the trial. Those with a dry cough are randomized to receive inhaled fluticasone or a matching placebo for two months, while those with a wet productive cough are randomized to receive oral amoxicillin–clavulanate or matching placebo for 14 days. The trial is double-blind so neither families nor researchers know which treatment a child receives. The main outcome is whether these commonly used treatments reduce or stop the prolonged cough compared with placebo.
Why it matters
Potential benefit: If successful, the treatments could shorten cough duration for affected children and help avoid unnecessary medications.
How similar studies have gone: Previous studies and reviews have produced mixed or limited evidence for inhaled steroids and antibiotics in prolonged pediatric cough, so this trial addresses an unresolved clinical question.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Prolonged cough lasting continuously for more than 4 weeks * No chronic disease requiring continuous medication (i.e. a generally healthy child) * No previous physician-diagnosed condition associated with prolonged cough episodes * No physician-identified symptoms or findings suggestive of an underlying disease * No prior physician-diagnosed allergic reaction or other severe or life-threatening adverse reaction to the investigational medicinal products (fluticasone or amoxicillin-clavulanic acid) * No simultaneous participation in another clinical drug trial * Parents/guardians have sufficient spoken and written Finnish language proficiency * Written, voluntary informed consent provided by a parent or legal guardian Exclusion Criteria: Children with symptoms or findings suggestive of an underlying cause of cough, including: * A previously physician-diagnosed disease associated with prolonged cough * Clinical examination or history at the study visit raising suspicion of a disease associated with prolonged cough (positive "cough pointers") * Abnormal lung function test * Abnormal chest X-ray (peribronchial markings are permitted) Additional exclusion criteria: * Prior physician-diagnosed allergic reaction or other severe or life-threatening adverse reaction to the investigational medicinal products * Simultaneous participation in another clinical drug trial * Prolonged cough that has resolved spontaneously prior to the study visit
Where it's running
-
Study Site: Tampere University Hospital (TAYS), Children's and Adolescents' Hospital Outpatient Paediatrics Unit P.O. Box 2000, FI-33521 Tampere, Finland
Tampere, Finland Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Cough and Airway Remodelling in Refractory Cough Patients
This study tests whether long-lasting chronic cough damages and remodels the airways in adults who have had cough for over a year and have not responded to prior treatments.
-
Brief, breath-focused ACT for adults with chronic cough
This pilot test checks if a short, breath-control-oriented Acceptance and Commitment Therapy program is doable, acceptable, and safe for adults who have chronic cough.
-
Behavioral therapy for persistent chronic cough
This program will try behavioral cough suppression therapy to help adults whose cough has lasted more than eight weeks and has not improved with usual treatments.
-
Biomarkers and Respiratory Omics in Children: Predicting Disease Course
This study tests whether biomarkers from the lungs and blood can predict how asthma and protracted bacterial bronchitis in children will progress and respond to current therapies.
-
Evaluating treatment satisfaction with gefapixant for chronic cough
This study is testing how satisfied adults with stubborn chronic cough are with the treatment gefapixant and whether any taste changes they experience affect their quality of life related to coughing.
-
Observing cough patterns in patients with chronic cough
This study is trying to understand different types of coughs in people with chronic cough by using a new questionnaire to see how often they cough and how it affects their daily life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.